Introduction
============

Diabetes mellitus is a major public health problem, and a marked increase in the disease burden is projected by 2025.[@b1-opth-6-1005] Diabetic retinopathy is a serious microvascular complication of diabetes mellitus and is a major cause of adult blindness. Relevant to this study, several cross-sectional studies have found a positive correlation between diabetes and primary open-angle glaucoma.[@b2-opth-6-1005]--[@b6-opth-6-1005] However, there have been other studies that failed to confirm this association.[@b7-opth-6-1005]--[@b13-opth-6-1005] Thus, the relationship between diabetes mellitus and open-angle glaucoma has not been established.

Several population-based studies have consistently reported that intraocular pressure (IOP) is significantly higher in subjects with diabetes than in those without diabetes,[@b2-opth-6-1005]--[@b7-opth-6-1005],[@b9-opth-6-1005],[@b10-opth-6-1005],[@b12-opth-6-1005],[@b14-opth-6-1005],[@b15-opth-6-1005] although some of them failed to find a positive correlation between diabetes and open-angle glaucoma.[@b7-opth-6-1005],[@b9-opth-6-1005],[@b10-opth-6-1005] The Japanese population-based Tajimi study reported that diabetic patients had significantly higher IOP, but the presence of diabetes was not significantly associated with the development of open-angle glaucoma.[@b16-opth-6-1005],[@b17-opth-6-1005] However, only limited data exist on the relationship between diabetes mellitus and IOP in the Japanese population, and earlier studies have not evaluated diabetic status, such as the glycosylated hemoglobin (HbA~1c~) level, and the effect of degree of diabetic retinopathy on IOP.[@b16-opth-6-1005],[@b17-opth-6-1005]

Thus, the purpose of this study was to determine whether a significant correlation exists between IOP and diabetes, the degree of diabetic retinopathy, and the HbA~1c~ level. To accomplish this, we examined the IOP of patients with diabetes mellitus and compared their IOP with that in subjects without diabetes mellitus.

Materials and methods
=====================

Participants
------------

The procedures used in this study conformed to the tenets of the Declaration of Helsinki. The medical records of all patients who first visited the Department of Ophthalmology, Kansai Medical University Takii Hospital (Osaka, Japan) between April 2008 and July 2009 were reviewed. At the initial examination, all patients were interviewed regarding their medical history, including past ocular diseases. Patients who underwent a standard ophthalmic examination, including determination of visual acuity, refraction, slit-lamp examination, and fundus examination were included in this study.

IOP was measured routinely three times with a noncontact tonometer (Topcon CT90, Topcon, Tokyo, Japan), and the average of the right eye was used for the statistical analyses. Patients who were \<20 years old, had corneal disease, uveitis, ocular inflammatory disease, and fundus diseases except for diabetic retinopathy were excluded. In addition, patients who had undergone any intraocular surgery, eg, for cataract, vitrectomy, glaucoma, or buckling surgery, were excluded. However, patients with mild cataracts in whom the fundus could be examined were included. Patients with definite glaucoma, suspected glaucoma,[@b9-opth-6-1005],[@b16-opth-6-1005],[@b17-opth-6-1005] or other types of glaucoma, including neovascular glaucoma, and those who were receiving IOP-lowering treatments were excluded. HbA~1c~ levels determined by standard laboratory procedures were obtained from medical records.

Classification of diabetic retinopathy
--------------------------------------

All patients included in this study underwent a standard ophthalmic examination at the initial visit. The stage of diabetic retinopathy was determined by ophthalmoscopy and fluorescein angiography. The patients were classified according to the severity of diabetic retinopathy; ie, no apparent diabetic retinopathy, mild to moderate nonproliferative diabetic retinopathy, severe nonproliferative diabetic retinopathy, and proliferative diabetic retinopathy.[@b18-opth-6-1005] Patients identified to have proliferative diabetic retinopathy underwent routine gonioscopy to exclude neovascular glaucoma. The association between IOP and the presence or absence of diabetes mellitus, gender, age, stage of diabetic retinopathy, and HbA~1c~ level were evaluated.

Statistical analyses
--------------------

The results are expressed as the mean ± standard error of the mean (SEM), and the data were analyzed statistically using the Mann--Whitney test and one-way analysis of variance with Dunnett's correction when comparing groups. Associations between the parameters were examined by Pearson's product moment correlation coefficients (r). The statistical analysis package SPSS 14.0 for Windows (SPSS Inc, Chicago, IL) was used for statistical processing. A *P* value \< 0.05 was accepted as significant.

Results
=======

Of the 703 patients, 206 were diagnosed with diabetes and 497 without diabetes. The mean (±standard deviation) age of the 206 diabetic patients was 61.4 ± 11.9 years with a range of 21 to 85 years. The 206 diabetic patients included 140 men (age 60.6 ± 10.8 years) and 66 women (age 63.2 ± 13.9 years). The mean age of the 497 nondiabetic patients was 61.7 ± 15.6 years with a range from 21 to 95 years. The 497 nondiabetic patients included 210 men (age 58.8 ± 16.2 years) and 287 women (age 63.9 ± 14.8 years).

The mean (±SEM) IOP was 14.0 ± 0.12 mmHg in the nondiabetic group and 15.5 ± 0.24 mmHg in the diabetic group ([Figure 1](#f1-opth-6-1005){ref-type="fig"}). The IOP in the diabetic patients was significantly higher than that in the nondiabetic patients (*P* \< 0.0001, Mann--Whitney test).

In the nondiabetic group, the mean IOP was 13.9 ± 0.2 mmHg in men (n = 210) and 14.2 ± 0.36 mmHg in women (n = 287); in the diabetic group, the mean IOP was 15.4 ± 0.27 mmHg in men (n = 140) and 15.8 ± 0.46 mmHg in women (n = 66, [Figure 2](#f2-opth-6-1005){ref-type="fig"}). Differences in IOP between the men and women in both groups were not significant (*P* = 0.17 in nondiabetic group, *P* = 0.64 in diabetes group, Mann--Whitney test).

The IOP was 15.6 ± 0.4 mmHg in patients with no apparent diabetic retinopathy (n = 95, age 61.1 ± 13.4 years), 15.7 ± 0.5 mmHg in patients with mild to moderate nonproliferative diabetic retinopathy (n = 46, 65.8 ± 9.16 years), 15.0 ± 0.5 mmHg in patients with severe nonproliferative diabetic retinopathy (n = 41, 60.2 ± 10.8 years), and 18.0 ± 2.2 mmHg in patients with proliferative diabetic retinopathy (n = 24, 56.9 ± 9.19 years, [Figure 3](#f3-opth-6-1005){ref-type="fig"}). The IOP in each diabetic retinopathy group was significantly higher than that in the nondiabetic group (*P* \< 0.001, one-way analysis of variance with Dunnett's test) but there was no significant difference between the diabetic retinopathy groups.

The IOP decreased significantly with increasing age in the diabetic patients, and a calculation of Pearson's product moment correlation coefficient (r) between IOP and age showed that the correlation was significant (r = −0.202, *P* = 0.024, n = 206, [Figure 4](#f4-opth-6-1005){ref-type="fig"}). The IOP also decreased with increasing age in the nondiabetic group but the decrease was not significant (r = −0.07, *P* = 0.12, n = 497).

The IOP of diabetic patients increased with increasing HbA~1c~ but the correlation was not significant (r = 0.142, *P* = 0.058, n = 179). When we examined the IOP of patients with diabetic retinopathy (patients with mild to moderate nonproliferative diabetic retinopathy, severe nonproliferative diabetic retinopathy, and proliferative diabetic retinopathy), there was a significant correlation between IOP and HbA~1c~ level (r = 0.240, *P* = 0.015, n = 102, [Figure 5](#f5-opth-6-1005){ref-type="fig"}).

Discussion
==========

Both glaucoma and diabetic retinopathy are leading causes of irreversible blindness worldwide.[@b19-opth-6-1005],[@b20-opth-6-1005] Diabetes mellitus is known to cause microvascular damage and may affect the autoregulatory action of the blood vessels in the retina and optic nerve. Diabetes has been found to be associated with elevated IOP and has therefore been suggested to be a possible risk factor for glaucoma, particularly open-angle glaucoma.[@b2-opth-6-1005]--[@b6-opth-6-1005]

However, the evidence to support this relationship remains inconsistent. The Baltimore Eye Survey[@b7-opth-6-1005] and some other studies[@b10-opth-6-1005],[@b16-opth-6-1005] reported that diabetes was significantly associated with higher IOP but not with the development of open-angle glaucoma. In addition, the recent Beijing Eye study[@b9-opth-6-1005] reported that ocular hypertension was significantly associated with diabetes as assessed independently in multivariate analysis but the prevalence of glaucomatous optic nerve damage was not associated with diabetes.

The gold standard for the measurement of IOP is the Goldmann applanation tonometer. However, IOP by noncontact tonometer is very popular and widely used for routine ocular examination and correlates well with the Goldmann applanation tonometer. Thus, we reviewed the IOP data from those patients who were examined routinely with a noncontact tonometer. Our results showed that patients with diabetes mellitus had significantly higher IOP than did nondiabetic patients.

The mechanisms that cause higher IOP in diabetic patients were not determined. An epidemiological study of the association between ocular hypertension and family history of patients with type 2 diabetes mellitus reported that genetic factors may play some role in ocular hypertension.[@b21-opth-6-1005] Another study showed that dysfunction of the autonomic system in diabetic patients might contribute to increased IOP.[@b22-opth-6-1005] It has been suggested that elevated blood glucose levels induces an osmotic gradient with consequent fluid shifts into the intraocular space which elevates the IOP.[@b5-opth-6-1005]

In addition, several large population-based cross-sectional studies have documented a significant correlation between elevated blood glucose or HbA~1c~ levels and raised IOP in diabetic patients.[@b2-opth-6-1005]--[@b4-opth-6-1005],[@b6-opth-6-1005],[@b10-opth-6-1005],[@b15-opth-6-1005] We also found that the IOP was significantly correlated with HbA~1c~ in patients with diabetic retinopathy, although the stage of diabetic retinopathy was not associated with IOP. Thus, high glucose in the blood or some aspects of glucose metabolism could affect IOP. Although a mean difference of 1.5 mmHg may not be clinically irrelevant in nonglaucomatous patients, it should be noted that HbA~1c~ levels raise IOP in diabetic patients.

In this study, IOP was not significantly associated with gender in either the diabetic or nondiabetic group, which is in agreement with the results of earlier studies.[@b19-opth-6-1005] Many studies have shown that the IOP increases with age.[@b3-opth-6-1005],[@b11-opth-6-1005],[@b14-opth-6-1005],[@b19-opth-6-1005] However, the recent Beijing[@b9-opth-6-1005] study did not find any significant correlation between IOP and age. Moreover, the Tajimi study[@b16-opth-6-1005] reported a significant negative correlation between age and IOP in the adult Japanese population. Therefore, the relationship between IOP and age is contradictory.

Our finding that the correlation between IOP and age was not significant in nondiabetic patients disagrees with the finding of the Tajimi study,[@b16-opth-6-1005],[@b17-opth-6-1005] but IOP decreased significantly with increasing age in patients with diabetes. One reason for this discrepancy in nondiabetic patients is that the Tajimi study was population-based, which was not the case in our study. Another reason may be that patients with glaucoma were excluded from our study.

The present study has some limitations. First, measurement of central corneal thickness (CCT) was not carried out. IOP measurement may depend on CCT,[@b23-opth-6-1005] and the CCT of diabetic patients has been reported to be greater when compared with that of nondiabetic patients.[@b24-opth-6-1005],[@b25-opth-6-1005] Even with use of the noncontact tonometer, the IOP measurement is still affected by CCT.[@b26-opth-6-1005] Thus, we may be concerned about the influence of a thick CCT on IOP measurement in diabetic patients. IOP is usually examined routinely, but CCT values are not examined routinely, so higher IOP levels in diabetics should be still considerable. In addition, glycation-induced corneal collagen cross-links in diabetes can cause corneal stiffening,[@b27-opth-6-1005] which has also been shown to increase the value of the measured IOP over the true IOP.[@b28-opth-6-1005],[@b29-opth-6-1005] Further, IOP is at least partly genetically mediated.[@b30-opth-6-1005] We only investigated the Japanese population, so it is possible that data from different genetic populations may yield different statistical results. In addition, this was a retrospective study. However, our results add to the evidence that diabetic patients have significantly higher IOPs, although this study was not designed to determine the mechanism for this relationship.

In conclusion, our findings showed that patients with diabetes mellitus had significantly higher IOP than nondiabetic patients. In addition, there was a significant positive correlation between IOP and HbA~1c~ levels in patients with diabetic retinopathy. These findings indicate that diabetic patients have higher IOP, especially those with poor control of diabetes.

**Disclosure**

The authors report no conflicts of interest in this work.

![IOP in patients with and without diabetes.\
**Notes:** The mean IOP was 14.0 ± 0.1 mmHg in the nondiabetes group (n = 497) and 15.5 ± 0.2 mmHg in the diabetes group (n = 206). The IOP in the diabetic patients was significantly higher than that in nondiabetic patients. \**P* \< 0.0001.\
**Abbreviation:** IOP, intraocular pressure.](opth-6-1005f1){#f1-opth-6-1005}

![Effect of gender on IOP.\
**Notes:** In the nondiabetes group, mean IOP was 13.9 ± 0.2 mmHg in men (n = 210) and 14.2 ± 0.4 mmHg in women (n = 287). In the diabetic group, mean IOP was 15.4 ± 0.27 mmHg in men (n = 140) and 15.8 ± 0.46 mmHg in women (n = 66). Differences in IOP between men and women were not significant in either group (*P* = 0.17 in the nondiabetes group, *P* = 0.64 in the diabetes group).\
**Abbreviation:** IOP, intraocular pressure.](opth-6-1005f2){#f2-opth-6-1005}

![Effect of progression of diabetic retinopathy on IOP.\
**Notes:** IOP was 15.6 ± 0.4 mmHg in patients with NDR (n = 95), 15.7 ± 0.5 mmHg in M-NPDR (n = 46), 15.0 ± 0.5 mmHg in S-NPDR (n = 41), and 18.0 ± 2.2 mmHg in PDR (n = 24). The IOP in each diabetic retinopathy group was significantly higher than that in their nondiabetic group (*P* \< 0.001), but there was no significant difference between the diabetic retinopathy groups. \**P \<* 0.001.\
**Abbreviations:** IOP, intraocular pressure; NDR, no apparent diabetic retinopathy; M-NPDR, mild to moderate nonproliferative diabetic retinopathy; S-NPDR, severe nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy.](opth-6-1005f3){#f3-opth-6-1005}

![Effect of age on IOP in diabetic patients.\
**Notes:** IOP decreased significantly with increasing age in diabetic patients (r = −0.202, *P* = 0.024, n = 206).\
**Abbreviation:** IOP, intraocular pressure.](opth-6-1005f4){#f4-opth-6-1005}

![IOP and HbA~1c~ in patients with diabetic retinopathy.\
**Notes:** IOP and HbA~1c~ of patients with diabetic retinopathy (patients with M-NPDR, S-NPDR, and PDR) were significantly correlated (r = 0.240, *P* = 0.015, n = 102).\
**Abbreviations:** IOP, intraocular pressure; HbA~1c~, glycosylated hemoglobin; M-NPDR, mild to moderate nonproliferative diabetic retinopathy; S-NPDR, severe nonproliferative diabetic retinopathy; PDR, proliferative diabetic retinopathy.](opth-6-1005f5){#f5-opth-6-1005}
